Entry Detail



General Information

Database ID:exR0354476
RNA Name:hsa-miR-373-3p
RNA Type:miRNA
Chromosome:chr19
Starnd:+
Coordinate:
Start Site(bp):53788748End Site(bp):53788770
External Links:hsa-miR-373-3p



Disease Information

Disease Name:Glioblastoma Multiforme
Disease Category:Cancers
MeSH ID:D005909
Type:Neoplasms/Neoplasms, Glandular and Epithelial
Alias:Glioblastoma//Glioblastomas//Astrocytoma, Grade IV//Astrocytomas, Grade IV//Grade IV Astrocytoma//Grade IV Astrocytomas//Glioblastoma Multiforme//Giant Cell Glioblastoma//Giant Cell Glioblastomas//Glioblastoma, Giant Cell//Glioblastomas, Giant Cell



Expression Detail

GEO ID:GSE93850
Description:Serum miRNAs in Patients with Glioblastoma Multiforme
Experimental Design:Cancer vs Control
Case Disease Type:Glioblastoma Multiforme
Case Disease SubType:NA
Case Sample:Glioblastoma Multiforme
Control Sample:Healthy
Number of Case:22
Number of Control:8
Number of Samples:30





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
VLDLR
chr9
2621787
2660056
+
USP24
chr1
55066359
55215364
-
CELF2
chr10
10798397
11336675
+
APP
chr21
25880550
26171128
-
KLHL28
chr14
44924319
45042322
-
RGMA
chr15
93035273
93089204
-
PFN2
chr3
149964904
150050788
-
FAM177A1
chr14
35044907
35113130
+
MBP
chr18
76978827
77133683
-
CUL1
chr7
148697914
148801110
+
MSL1
chr17
40121971
40136917
+
RIT1
chr1
155897808
155911404
-
ATXN1
chr6
16299112
16761491
-
ZFAND4
chr10
45615500
45672780
-
SETD7
chr4
139495941
139606699
-
BAZ1B
chr7
73440406
73522293
-
AMPD2
chr1
109616104
109632053
+
SLC16A14
chr2
230034982
230068993
-
PHC3
chr3
170086732
170181749
-
FAM222B
chr17
28755978
28855232
-
PLEKHM1
chr17
45435900
45490749
-
SYAP1
chrX
16719612
16765340
+
ARL4A
chr7
12686856
12690958
+
RACGAP1
chr12
49976923
50033136
-
LONP2
chr16
48244300
48363122
+
CLIP4
chr2
29097705
29189643
+
ADAR
chr1
154582057
154628013
-
MAGI3
chr1
113390515
113685923
+
NAA16
chr13
41311267
41377030
+
CLOCK
chr4
55427903
55546909
-
miRNA targets:NA
circRNA targets:
circRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa_circ_0000943
chr19
47421744
47440665
+
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC125257.1
chr17
41848518
41851447
-
AL049840.4
chr14
103694516
103695050
-
ARHGAP27P1-BPTFP1-KPNA2P3
chr17
64749663
64781707
-
FGD5-AS1
chr3
14920347
14948424
-
MIR17HG
chr13
91347820
91354579
+
NEAT1
chr11
65422774
65445540
+
NORAD
chr20
36045618
36051018
-
SNHG16
chr17
76557764
76565348
+
XIST
chrX
73820649
73852723
-
Display:



Experiment Detail

GEO ID:GSE93850
Sample Source:Blood
Source Fraction:Serum
Platform:GPL22948
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:1032
Sample treatment protocol:NA
RNA Extract protocol:Serum total RNA was isolated from serum samples using the Plasma/Serum Circulating and Exosomal RNA Purification Mini Kit (Slurry Format) (Norgen Biotek Corporation, Thorold, Ontario, Canada)
RNA library preparation protocol:0.3ug of total RNA of intrahepatic cholangiocarcinoma/normal intrahepatic bile duct tissue was employed with 100 nmol/L of pCp-DY547 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 ul at 16°C overnight.



Reference

PMID:28931080
Title:Low serum level of miR-485-3p predicts poor survival in patients with glioblastoma
Author:Wang ZQ, Zhang MY, Deng ML, Weng NQ, Wang HY,Wu SX
Journal:PLoS One. 2017 Sep 20;12(9):e0184969.
Description:we investigated whether 3 of the 19 miRNAs in serum could be used as prognostic biomarkers for patients with GBM.